What does Aprogen Medicines Inc. do?

Aprogen Medicines Inc. (007460.KS) operates in the Conglomerates industry within the Industrials sector. Full company description, peers, and segment breakdown are on the page above.

What is 007460.KS's market cap?

Aprogen Medicines Inc. (007460.KS) has a market capitalization of approximately $3.32 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 007460.KS pay a dividend?

Yes — Aprogen Medicines Inc. (007460.KS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

007460.KS

Aprogen Medicines Inc.

KSC·Conglomerates · Industrials

₩2,365₩335−12.41%

Market cap₩3.32B·Market closed·Aug 27 6:30 AM UTC

Price Chart

₩2,365−₩335.00 (−12.41%)today

−99.83%CAGR −71.97%

Select date range

FromTo

Sep 29, 2005Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

007460.KS does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateApr 7

Last Report DateFeb 10

Reported vs Estimate₩12.49

Earnings Surprise—

FinancialsFinancials Tab

Revenue₩138.90B

Net Income−₩82.81B

Net Margin−59.6%

Operating Cash Flow−₩63.90B

Capital Expenditures₩22.83B

Free Cash Flow−₩86.73B

Return on Equity−136.8%

Return on Invested Capital−4.3%

Net Debt₩138.28B

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 007460.KS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 007460.KS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 007460.KS and 80,000+ other tickers.

About Aprogen Medicines Inc.

Founded in 1971 and headquartered in Seongnam-si, South Korea, Aprogen Medicines Inc. (formerly Aprogen KIC Inc. until its name change in April 2021) specializes in the design, manufacture, and maintenance of plant facilities. Their services cater to crucial sectors including steelwork, petrochemistry, shipbuilding, power generation, and liquefied natural gas (LNG) base industries. The company also provides thermal and cold spray services, a diverse range of clad products such as rolls, plates, wear plates, pipes, and fittings, along with plasma transferred arcs. Furthermore, Aprogen…

CEO: Jaeseob Kim
Sector: Industrials
Industry: Conglomerates
Exchange: KSC
Employees: 311
Website: www.aprogen.com

Peers

Leeku Industrial Co., Ltd.

Cap

₩152.8B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 007460.KS

What does Aprogen Medicines Inc. do?: Aprogen Medicines Inc. (007460.KS) operates in the Conglomerates industry within the Industrials sector. Full company description, peers, and segment breakdown are on the page above.
What is 007460.KS's market cap?: Aprogen Medicines Inc. (007460.KS) has a market capitalization of approximately $3.32 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 007460.KS pay a dividend?: Yes — Aprogen Medicines Inc. (007460.KS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.